Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)
LOS ANGELES, May 10, 2025 (GLOBE NEWSWIRE) -- Losing weight these days can feel more difficult than ever. Despite trying...
Day: May 10, 2025
Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL...
6 Best Fat Burners For Women: Top Over the Counter and Online Pills and Fat Burning Supplements For Women Weight Loss In 2025 – Wolfson Brands
Discover the 6 best fat burners for women in 2025. Top OTC & online weight loss pills from Wolfson Brands...
Best Fat Burners For Men 2025: Top Weight Loss Pills & Supplements For Fast Fat Loss – Wolfson Brands Ltd
Discover the best fat burners for men in 2025! Our expert guide ranks the top weight loss pills and supplements...
4 Best Supplements for Muscle Growth in 2025 – Legal Steroid Alternatives & Bodybuilding Supplements for Bulking and Strength – Wolfson Brands
WOLFSON BRANDS (UK) LIMITED WOLFSON BRANDS (UK) LIMITED Glasgow, May 10, 2025 (GLOBE NEWSWIRE) -- The best legal supplements for...
Activists Mark Luigi Mangione’s Birthday With Aerial Protest as Times Square Billboard on Jury Rights Explodes Online
Two independent campaigns in NYC spotlight healthcare and legal reform amid public outcry over Luigi Mangione’s case. Image by POPNYC...
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes...
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month...
HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health...
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following...